Practically Speaking : Covid-19 Anti-Virals and Systemic Cancer Therapy

To be added to the distribution list email: DDeCastro@southlakeregional.org

This episode will review the practical use of Covid Anti-viral medications in patients receiving systemic anti-cancer therapies.  Dr. Zipursky will review the clinically relevant literature on anti-virals and  will focus on interactions to look out for between the currently available anti virals and common systemic therapies. 

Key Opinion Leader: 
Dr. Jonathan Zipursky 
jonathan.zipursky@sunnybrook.ca

Internal Medicine, Clinical Pharmacology & Toxicology (Clinical Associate)
Sunnybrook Health Sciences Centre and Mount Sinai Hospital

Host:
Dr. Shaqil Kassam 
skassam@southlakeregional.org 
Medical Oncologist 
Stronach Regional Cancer Centre, Newmarket, Ontario 

POD Cast Legend:
Introduction: 0:00
Paxlovid mechanism of action: 3:40
The Landmark Trial: EPIC-HR: 7:40
Paxlovid and Cancer Patients: 12:17
Resources to check for Paxlovid interactions: 22:30 
Delaying treatments for patients on Paxlovid (Half Lives): 26:20
Writing the Script: 29:00
Paxlovid and Specific systemic Cancer therapies: 32:50.

Previous Episodes: 
Gastric Cancer: http://tobtr.com/12051154
NGS: http://tobtr.com/12072620